Free shipping

Otilonium for IBS: What OBIS Measured

Pain frequency and broader response gave different answers.

Woman discussing an open symptom notebook at a green table.
In this article
  1. Which pain measure?
  2. What did follow-up mean?
  3. How should prescribing differ?

Before trying a medicine for IBS, decide what you want it to change: how often pain occurs, how much it hurts, or how bowel symptoms affect your day. Bring that goal and a symptom record to the appointment, then agree how you will assess the result.

Which pain measure?

OBIS randomized 356 adults with stable Rome II IBS to otilonium 40 mg three times daily or placebo for 15 weeks; 339 entered the efficacy analysis. Its primary pain-frequency score ran 0–3, categorizing weekly episodes as none, 1–3, 4–7 or eight-plus.1

Mean scores fell 0.90 versus 0.65 points (P=0.038). These are score changes, not fewer episodes. Pain intensity and several responder measures did not differ significantly. Missing observations were carried forward. Menarini sponsored the trial.1

What did follow-up mean?

Ten-week follow-up after stopping was restricted to successful patients: 162 were analyzed. Success meant fewer than two weekly pain episodes in the final fortnight. Reported relapse withdrawals favored otilonium; that selected subset cannot establish protection for every patient.1

How should prescribing differ?

Spain’s AEMPS2 technical information for Otilonio ratiopharm 40 mg film-coated tablets specifies adult gastrointestinal spastic conditions and dyskinesias and a maximum four-week course. That named product’s instructions should not be replaced by the research schedule above. Ask your prescriber to check the exact locally supplied product, indication and duration.2

The Spanish label contraindicates intestinal obstruction, advises caution with glaucoma, kidney or liver impairment and multiple medicines, and does not recommend use during pregnancy or breastfeeding. Interaction studies have not been performed; this does not mean combinations are risk-free. Bring prescriptions, over-the-counter products and supplements for review.2

The British Society of Gastroenterology’s3 2021 guideline gives certain antispasmodics a weak recommendation based on very low-quality evidence for IBS symptoms and pain. It lists dry mouth, visual disturbance and dizziness among common class effects. A favorable result for one outcome does not identify the best medicine for your bowel pattern. Agree which benefit would justify continuing and when to review side effects.3

Bloated by Dinner includes “The Visit Script”: bring your symptom and stool record, summarize the pattern, list medicines and dietary changes, and ask what has been ruled out and what comes next. Use those prompts to make the follow-up appointment more specific than simply reporting that your stomach feels better or worse.

Discuss medicines with your clinician. Research schedules are not prescriptions.

Read our health disclaimer

Girl Playbook sells this book. It provides education and worksheets, not individualized medical care.

Sources

The research behind this article, in the order it’s cited. How we source our articles.

  1. Clavé and colleagues, 2011Otilonium bromide: the OBIS trial (opens in a new tab)abc
  2. AEMPS, Accessed 2026Otilonio ratiopharm 40 mg: Spanish technical information (opens in a new tab)abc
  3. British Society of Gastroenterology, 2021Guidelines on irritable bowel syndrome (opens in a new tab)ab

Spotted something out of date? Tell us and we’ll check it.

Private questions deserve good answers.

Ten Playbooks, one for each of the problems women rarely talk about.

Shop the Playbooks